Failure to Optimise anti-anginal theRapy in anGina pEcToris (FORGET)

被引：0
|
作者：
Elder, D. H. J. [1 ]
Pauriah, M. [2 ]
Lang, C. C. [2 ]
Shand, J. [3 ]
Menown, I. [3 ]
Sin, B. [4 ]
Gupta, S. [4 ]
Duckett, S. [5 ]
Foster, W. [6 ]
Kalra, P. [7 ]
机构：
[1] Ninewells Hosp, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Dundee, Scotland
[3] Craighavon Cardiac Ctr, Craighavon, South Africa
[4] Whipps Cross Univ Hosp NHS Trust, London, England
[5] Southampton Univ Hosp NHS Trust, Southampton, Hants, England
[6] Royal Bournemouth Hosp, Bournemouth, Dorset, England
[7] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：737 / 738
页数：2
相关论文
共 50 条
  • [1] THERAPY OF ANGINA PECTORIS - EVALUATION OF ANTI-ANGINAL AGENTS AND PROCEDURES
    COLE, SL
    DISEASES OF THE CHEST, 1958, 34 (03): : 330 - 334
  • [2] Failure to Optimise Therapy in Angina Pectoris
    Elder, Douglas H.
    Pauriah, Mahesh
    Lang, Chim C.
    Shand, James
    Menown, I.
    Sin, Barron
    Gupta, S.
    Duckett, S.
    Kalra, Paul
    CIRCULATION, 2009, 120 (18) : S525 - S525
  • [3] ANTI-ANGINAL EFFECT OF THE CALCIUM-ANTAGONIST BEPRIDIL IN STABLE ANGINA-PECTORIS
    SCHNEIDER, W
    MEHLHORN, C
    KALTENBACH, M
    BUSSMANN, WDD
    ZEITSCHRIFT FUR KARDIOLOGIE, 1985, 74 (06): : 341 - 347
  • [4] CPMP note for guidance: Clinical investigation of anti-anginal drugs in stable angina pectoris
    Morros, R
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1996, 18 : 35 - 36
  • [5] Anti-anginal and anti-ischemic effects of the selective β-blocker talinolol in patients with stable angina pectoris
    Faulhaber, HD
    Weigmann, I
    Lang, U
    Weinsberg, F
    Terhaag, B
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (02) : 63 - 70
  • [6] Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?
    Elder, D. H. J.
    Pauriah, M.
    Lang, C. C.
    Shand, J.
    Menown, I. B. A.
    Sin, B. D. W. C. K.
    Gupta, S.
    Duckett, S. G.
    Foster, W.
    Zachariah, D.
    Kalra, P. R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (05) : 305 - 310
  • [7] COMPARISONS AND COMBINATIONS IN ANTI-ANGINAL THERAPY
    JULIAN, DG
    EUROPEAN HEART JOURNAL, 1985, 6 : 37 - 45
  • [8] METHODS OF EVALUATING ANTI-ANGINAL THERAPY
    WEBER, S
    DELAHAYE, JP
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1989, 82 (12): : 2077 - 2081
  • [9] Fibrinolytic parameters are associated with the risk for cardiovascular events in patients with stable angina pectoris on anti-anginal treatment.
    Held, C
    Hjemdahl, P
    Rehnqvist, N
    Wallen, HN
    Forslund, L
    Bjorkander, I
    Eriksson, SV
    Wiman, B
    CIRCULATION, 1996, 94 (08) : 457 - 457
  • [10] ANTI-ANGINAL EFFECTS OF BEPRIDIL - A NEW CALCIUM-CHANNEL BLOCKER - IN PATIENTS WITH STABLE ANGINA-PECTORIS
    NARAHARA, KA
    SHAPIRO, W
    PARK, J
    WELIKY, I
    CLINICAL RESEARCH, 1983, 31 (01): : A15 - A15
12345